Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ayahuasca, Esketamine and PTSD — Stella

Home/Posttraumatic Stress Disorder (PTSD)/Ayahuasca, Esketamine and PTSD

View on ClinicalTrials.gov

Recruiting

Back to Posttraumatic Stress Disorder (PTSD) trials

Ayahuasca, Esketamine and PTSD

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Brazil

Hospital das Clínicas da FMRP-USP, Ribeirão Preto, São Paulo

Key details

Phase

Safety & dosing

Sponsor

University of Sao Paulo

Enrollment target

~10 participants

Started

December 2025

Primary completion

June 2026

Age range

18 Years – 65 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.